Industria 4.0 is present in smart and digital manufacturing, making manufacturing companies improve productivity, reducing delivery time and related costs. The objective of this work is to demonstrate through three integrated MPS Festo stations (Distribution, Pick \& Place and Sorting), using the Internet of Things and Google Analytics technologies, the benefits in relation to remote performance monitoring. The intended objective is achieved through the implementation of the monitoring system at the three MPS Festo stations. The data obtained through the integration of the Festo stations and their respective sensors are processed and analyzed in a cloud infrastructure, so that the main metrics are visualized and transmitted on a panel. This monitoring system improves the perception of process performance, as the main performance metrics are displayed, such as productivity, cycle time and parts produced. The cloud infrastructure allows remote viewing and monitoring of the system.

Microplastics (MPs) are small pieces of plastics. They are ubiquitous in the environment and can enter the freshwater environment from surface run-off and wastewater effluent (treated and untreated), industrial effluent, degraded plastic waste, and atmospheric deposition. They are not usually destroyed but convert into one phase to another. They are a source of air pollution, occurring in dust and airborne fibrous particles. Mostly MPs are non-biodegradable while some MPs are biodegradable, which can be decomposed in the presence of ultraviolet (UV) light or by the action of microorganisms. Popular methods: chemical, spectroscopic, and thermo-analytical are available for the determination of the chemical composition and size of plastic particles. This chapter discusses the uses, health hazards, sources, and transport of MPs particles.

The mucopolysaccharidoses (MPS) are a group of 11 lysosomal storage diseases (LSDs) produced by mutations in the enzymes involved in the lysosomal catabolism of glycosaminoglycans. Most of the mutations affecting these enzymes may lead to changes in processing, folding, glycosylation, pH stability, protein aggregation, and defective transport to the lysosomes. The use of small molecules, called pharmacological chaperones (PCs), that can restore the folding, trafficking and biological activity of mutated enzymes has been extensively explored in LSDs as a therapeutic alternative. PCs have the advantage of wide tissue distribution, potential oral administration, lower production cost, and fewer issues of immunogenicity. In this paper, we will review the advances in the identification and characterization of PCs for the MPS. These molecules, mainly based in molecules mimicking the enzyme substrates, have been described for MPS II, IVA, and IVB, showing a mutation-dependent enhancement of the mutated enzymes. Although the results show the potential of this strategy, further studies should focus in the development of disease-specific cellular models that allow a proper screening and evaluation of the identified PCs. In addition, in vivo evaluation, both pre-clinical and clinical, should be performed, before they can become a real therapeutic strategy for the treatment of MPS patients.

Abstract: Antimicrobial peptides (AMPs) are short peptides, usually made up of less than 100 amino acid residues. They are found in many living organisms and are an important factor in their innate immune systems. AMPs can be extracted from various living sources including bacteria, plants, animals and even humans. They are usually cationic peptides with an amphiphilic structure, which allows them to easily bind and interact with the cellular membranes of viruses, bacteria, fungi and other pathogens. They can act against both Gram-negative and Gram-positive pathogens and have various modes of action against them. Some attack the pathogens membrane, while others target their intracellular organelles as well as their nucleic acids, proteins and metabolic pathways. A crucial area of use of AMPs is in their ability to help with emerging antibiotic resistance: some AMPs are active against resistant strains and are susceptible to peptide engineering. This review considers AMPs from three key sources: plants, animals and humans, as well as their modes of action and some AMPs sequences.

Micro-plastics (MPs) become significantly important to society since their commercial manufacture began in the 1950s because of their low production costs, stability, light weight, and adaptability. Plastic was produced in 400 million tons worldwide in 2020, compared to 1.5 million tons just 60 years earlier. Scientists predict that by 2050, plastic production would increase to 33 billion tons. MPs are a rising scientific and societal issue in the environment as a new type of contaminant that is widely disseminated in aquatic ecosystems and organisms. Aquatic species that come into contact with MPs for an extended period of time experience ecotoxicity, which includes oxidative stress, genotoxicity, neurotoxicity, and reproductive issues. In aquatic environments, MPs not only transport chemicals within animals but also serve as mediators for chemicals or other contaminants. As a result of co-exposure of MPs and chemical contaminants, various toxicity incidences involving aquatic organisms have been reported. The final exposure of MPs occurs in humans through biomagnification of aquatic edible products. This study presents an important overview of the literature on MP ingestion by aquatic biota. It covers topics such as the present scenario of plastic pollution worldwide, the pathways that MPs take to reach humans and aquatic species, the eco-toxicological impacts of MPs on aquatic species, the relation between MPs and other environmental pollution and the ensuing effects on aquatic organisms, and the MP pollution status in Bangladesh.

Antarctica and its surrounding environment are considered untouched and thought that it is free from microplastics (MPs) pollution. However, recent studies and science projects have reported MPs in both water and sediment in the South Polar Regions. The reports state that the MP’s pollution occurs in this region due to fishing, tourism, and research activities by the nearby countries and nature's circulation is also part of it. The Antarctic Treaty System (ATS) has received attention on MP’s pollution and initiated research on it. MPs are tiny plastic particles with a size of less than 5 mm. It has two types, 1. Primary MPs have been manufactured directly for various applications like cosmetics and scrubbing etc 2. The secondary MPs are generated by photochemical degradation of large plastics.Although several studies have been done there is a quite gap in our understanding of the concentration, characteristics, and impact of plastics on the ecosystem of the Antarctic Region. The impact of MP’s pollution in this region may be very high. The presence of MP is a serious issue that is affecting not only the aquatic environment but also humans. It is an alarming situation that causes environmental damage. The main objective of this paper is to review MP's introduction, occurrence, sources, harmful effects, and detection methods. This review highlighted the various methodologies and analyses like density separation, microscope observation of MP’s properties Fourier-transform infrared spectroscopy (FTIR), and Raman spectrometer respectively, and urged for more research in the future and gave several recommendations to maintain the pristine region near Antarctica.

Organ-on-a-Chip (OoC) systems bring together cell biology, engineering, and material science for creating systems that recapitulate the in vivo microenvironment of tissues and organs. The versatility of OoC systems enables in vitro models for studying physiological processes, drug development, and testing in both academia and industry. This paper evaluates current platforms from the end-user perspective, elaborating on usability, complexity, and robustness. We surveyed 165 peers in over 30 countries and grouped the responses according to preliminary knowledge and the source of the OoC systems that are used. The survey clearly shows that current commercial OoC platforms provide a substantial level of robustness and usability - which is also indicated by an increasing adaptation of the pharmaceutical industry but a lack of complexity can challenge their use as a predictive platform. Self-made systems on the other hand are less robust and standardized but provide the opportunity to develop customized and more complex models which are often needed for human disease modeling. This review serves as a guide for researchers in the OoC field and encourages the development of next-generation OoCs.